Citi Pharma Limited (PSX:CPHL)

Market Cap	20.84B
Revenue (ttm)	13.15B
Net Income (ttm)	892.04M
Shares Out	228.46M
EPS (ttm)	3.90
PE Ratio	23.39
Forward PE	14.48
Dividend	3.50 (3.86%)
Ex-Dividend Date	Oct 17, 2025

Volume	1,769,814
Average Volume	5,010,316
Open	91.94
Previous Close	90.67
Day's Range	90.00 - 92.50
52-Week Range	38.30 - 109.30
Beta	0.56
RSI	43.92
Earnings Date	Oct 7, 2025

About Citi Pharma

Citi Pharma Limited engages in the manufacture and sale of pharmaceutical, medical chemical, and botanical products in Pakistan. Its product portfolio includes capsules, tablet, syrup drops, ointment, sachet, and formulation. Citi Pharma Limited was incorporated in 2012 and is headquartered in Lahore, Pakistan.

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 2012
• Employees: 531
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: CPHL

Financial Performance

In 2025, Citi Pharma's revenue was 13.15 billion, an increase of 6.00% compared to the previous year's 12.41 billion. Earnings were 892.04 million, an increase of 7.03%.